UHS
Universal Health Services
Health Care · Health Care Facilities · US

$168.91
Close 2026-05-15
✓ ETHICAL PASS

NARROW MOAT

HIGH
Data Confidence: 100%
Full financial profile available

Market Cap
$10.2B
Trailing P/E
7.05
Forward P/E
6.65
Rev Growth
+9.6%
Profit Margin
8.6%
ROE
21.4%
Analyst Target
$223.31
Recommendation
BUY

About Universal Health Services

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company’s hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

Opportunity Summary
Trading at $169 against a fair value of $305, a 45% discount. Passes all ethical screens. Ranks better than 96% of screened stocks.

Ethical Screen
Business Activity PASS
Debt Ratio (0.33%) PASS
Cash Ratio (0.00%) PASS
Receivables Ratio (0.18%) PASS
Revenue Ratio (0.00%) PASS
Overall PASS
Score Ethical: 83.1
Score Valuation: 95.0
Score Quality: 61.2
Score Combined: 66.2
Fair Value Est: $304.96 · Margin of Safety: +44.6% · Tier: OPPORTUNITY

Full Analysis

Opportunity scores, earnings history, insider transactions, institutional holders, analyst consensus, and more.

Unlock with Membership

Opportunity Scores
Valuation100.0
Quality73.3
Cash Flow78.8
Moat70.0
Balance Sheet79.4
Debt Purity0.0
Liquid Purity100.0
Rev Purity99.9
Compliance58.8
Tier: GOLD · Score: 79.9 · Rank: #73

Earnings History (Last 8 Quarters)
Date EPS Est. Reported EPS Surprise %
2026-07-27 5.89 Pending
2026-04-27 5.29 5.65 +6.9%
2026-02-25 5.89 7.06 +19.9%
2025-10-27 4.95 5.69 +14.9%
2025-07-28 4.96 5.35 +8.0%
2025-04-28 4.36 4.84 +11.1%
2025-02-26 4.18 4.96 +18.6%
2024-10-24 3.70 3.71 +0.3%

Quarterly Financials
Period Revenue Net Income EBITDA Gross Profit Op. Income EPS
2026-03-31 $4.5B $348.7M $660.5M $4.1B $502.9M 5.71
2025-12-31 $4.5B $445.9M $786.0M $4.1B $517.2M 7.19
2025-09-30 $4.5B $373.0M $689.3M $4.1B $521.7M 5.92
2025-06-30 $4.3B $353.2M $659.9M $3.9B $500.3M 5.49
2025-03-31 $4.1B $316.7M $608.0M $3.7B $454.8M 4.87
2024-12-31

Insider Transactions
Date Name Role Shares Value
2026-03-26 MILLER ALAN B Officer, Director and Beneficial Owner 14,153
2026-03-26 MILLER MARC D Chief Executive Officer 29,715
2026-03-26 PETERSON MATTHEW JAY Officer 5,627
2026-03-26 SIM EDWARD H. Officer 6,404
2026-03-26 FILTON STEVEN G. Chief Financial Officer 6,850
2026-03-13 SUSSMAN ELLIOT J Director 674 $128.1K
2026-03-13 SUSSMAN ELLIOT J Director 2,500 $347.0K
2026-03-12 MILLER MARC D Chief Executive Officer 100,425 $14.6M
2026-03-12 SINGER MARIA RUDERMAN Director 2,500 $347.0K
2026-03-12 FILTON STEVEN G. Chief Financial Officer 83,237 $12.2M
Top Institutional Holders
Holder Shares Value % Held
First Eagle Investment Management, LLC 4.4M $698.2M 0.1%
Blackrock Inc. 4.3M $685.7M 0.1%
Vanguard Capital Management LLC 3.5M $544.9M 0.1%
State Street Corporation 2.6M $407.0M 0.0%
Vanguard Portfolio Management LLC 2.5M $395.8M 0.0%
Geode Capital Management, LLC 1.9M $307.4M 0.0%
Pzena Investment Management LLC 1.9M $301.8M 0.0%
Dimensional Fund Advisors LP 1.8M $281.1M 0.0%
Invesco Ltd. 1.6M $250.8M 0.0%
Goldman Sachs Group Inc 1.3M $210.0M 0.0%

Analyst Recommendations
3 Months Ago
2
6
10
19 analysts

2 Months Ago
2
6
10
19 analysts

Last Month
2
6
10
19 analysts

Current
2
6
10
19 analysts

Strong Buy
Buy
Hold
Sell
Strong Sell

Additional Fundamentals
Enterprise Value
$14.7B
Price/Book
1.28
Beta
1.130
Analysts
16
Total Revenue (TTM)
$17.8B
Total Debt
$5.1B
Earnings Growth
+17.7%
Dividend Yield
0.5%
Rec. Mean
2.32
Short Ratio
3.93
Short % Float
0.1%
Employees
101,500

Elite Intelligence

Trade Consideration with position sizing, convergence signals, and risk analysis. Available to Elite members.

Upgrade to Elite

Trade Consideration

The Opportunity
Score 66.2 (P99 — top 0.7% of scored tickers). Narrow Moat. Ethical PASS. 16 analysts at Buy.
Price: $168.91 | Target: $221.44 (+31%) | Fair Value: $304.96 (+81%)

Score
66

Moat
NARROW

Conviction
Standard

Upside
+31%

The Fundamentals
Revenue Growth+9.6%
Profit Margin8.6%
ROE21.4%
Forward P/E6.6
Market Cap$10.2B

Earnings Track Record
Date Estimate Reported Surprise
2026-07-27 $5.89 Pending
2026-04-27 $5.29 $5.65 +6.9%
2026-02-25 $5.89 $7.06 +19.9%
2025-10-27 $4.95 $5.69 +14.9%
2025-07-28 $4.96 $5.35 +8.0%
2025-04-28 $4.36 $4.84 +11.1%
Position Sizing Scenarios
Stop: $143.57 (-15%) | Entry: $168.91
Shares Cost Profit to Target R:R
To Consensus ($221.44, 16 analysts)
10 $1,689.10 +$525.30 (31%) 2.1R
50 $8,445.50 +$2,626.50 (31%) 2.1R
100 $16,891.00 +$5,253.00 (31%) 2.1R
To Fair Value ($304.96)
10 $1,689.10 +$1,360.50 (81%) 5.4R
50 $8,445.50 +$6,802.50 (81%) 5.4R
100 $16,891.00 +$13,605.00 (81%) 5.4R
Risk Factors
  • Elevated short interest (3.93 days to cover)

The Verdict
Universal Health Services passes all ethical screens, holds a narrow competitive moat, and trades at a 44.6% discount to fair value.

Quantitative Grade

A single score combining all analytical layers below. A is strongest, D is weakest.

D
Quant Score
31.6
Risk Grade
LOW_RISK
Layers
8
Quality: CONSISTENT_BEATER

Risk Profile

How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.

VaR 95%
-3.5%
worst expected daily loss, 19 in 20 days
CVaR 95%
-5.5%
avg loss on the worst 5% of days
Annual Volatility
Sortino Ratio
-0.19
above 1.0 is good
Max Drawdown
-35.7%
Worst Day

Forward Outlook

Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.

30d Prob Up
90d Prob Up
Median Return 30d
Liquidity Score
85
Liquidity Grade
HIGHLY LIQUID

Trend & Momentum

What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?

Kalman Trend
Trend Strength
Momentum Signal
HMM Regime
RSI Signal

Technical Signals

Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.

MA Crossover
DEATH_CROSS
Bollinger Position
BELOW_LOWER
Beta
Relative Volume
2.2x
Short Interest

Financial Health

Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.

Altman Z-Score
below 1.81 = distress zone

Piotroski F-Score

Earnings Beat Rate
100.0%
Earnings Consistency

Correlations

These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.

Most Correlated
Ticker Correlation
HCA 0.722
HIG 0.427
CON 0.426
ARDT 0.417
PNTG 0.413
Inverse Correlated
Ticker Correlation
NTSK -0.185
NAVN -0.177
DIN.AE -0.157
VIA -0.154
SUKOON.AE -0.152

Seasonality

Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.

Best Day
Wednesday
Worst Day
Friday
Best Month
Aug
Worst Month
Dec
Fri-Mon Effect
-0.5320535507366339

Earnings Drift

After this company beats earnings, does the price keep going up? Drift tracks post-earnings momentum.

Avg Drift After Beat
+2.7%
Beat Drift Positive %
62.5%
Consistency

Momentum Rankings

How does this ticker’s recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.

1M Return
-10.2%
3M Return
-31.8%
6M Return
-30.4%
12M Return
-15.8%
Momentum Rank
#4228
Momentum Signal
STRONG_DOWN

Related Tickers

Similar in Healthcare

INCY — Incyte CRMD — CorMedix Inc. ✓ FENC — Fennec Pharmaceuticals Inc. ✓ REGN — Regeneron Pharmaceuticals ✓ DVA — DaVita

Also in TE500

NEM — Newmont ✓ NU — Nu Holdings Ltd. PTC — PTC Inc. ✓ SBNY — Signature Bank EXE — Expand Energy ✓
Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry Indicators Options Calendar Composites Boycott Tracker Convergence Screener Fed Tracker Explore All Is It Halal? Earnings Calendar Dividend Screener Country Guides Glossary Join Free →

Get our weekly market brief free.